BNP PARIBAS FINANCIAL MARKETS - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 60 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2013. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$53,398,000
+196.2%
5,953
+77.3%
0.00%
Q2 2016$18,027,000
+18484.5%
3,357
+15885.7%
0.00%
Q1 2016$97,000
-99.9%
21
-99.9%
0.00%
Q4 2015$93,600,000
-76.2%
18,000
-72.3%
0.00%
-100.0%
Q3 2015$393,196,000
-84.8%
64,991
-60.2%
0.00%
-85.7%
Q2 2015$2,580,970,000
+15953.8%
163,456
+10951.8%
0.01%
Q1 2015$16,077,000
-56.5%
1,479
-61.6%
0.00%
Q3 2014$36,969,000
+267.3%
3,855
+398.7%
0.00%
Q4 2013$10,065,000
-95.7%
773
-95.0%
0.00%
Q3 2013$232,677,000
+28.0%
15,595
-19.8%
0.00%
Q2 2013$181,820,00019,4460.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q2 2013
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders